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Abstract
Background: Patient Reported Outcomes (PRO) are gaining more and more importance in the context of clinical
trials. The assessment of PRO is frequently performed by questionnaires where the multiple items of a questionnaire
are usually pooled within summarizing scores. These scores are used as variables to measure subjective aspects of
treatments and diseases. In clinical research, the calculation of these scores is mostly kept very simple, e.g. by a
simple summation of item values. In the medical literature, there is hardly any guidance for performing a
refinements of questionnaires and for deducing adequate scores. In contrast, in psychometric literature, there are
plenty of more sophisticated methods, which overcome typical assumptions made in traditional (sum) scores,
however to the prize of more complicated algorithms, which might be difficult to communicate. When faced with
the practical task to refine an existing questionnaire, there exist a clear gap of guidance for applied medical
researchers. By this article we try to fill this important gap between psychometric theory and medical application by
illustrating our methodological choices on the example of a clinical PRO questionnaire.
Methods: Based on our experiences with the refinement of the BCTOS, a PRO questionnaire to assess aesthetic and
function after breast conserving therapy in breast cancer patients, we present the following general steps that we
performed by refining the BCTOS questionnaire and its scores: 1. Refinement of the length of the questionnaire and
the (item-factor) structure. 2. Selection of the factor score estimation method. 3. Validation of the refined
questionnaire and scores with respect to validity, reliability and structure based on a validation cohort.
Results: Our step-step-step procedure helped us to shorten the current form of the BCTOS and to redefine the
factor structure. By this, the compliance of patients can be increased and the interpretation of the results becomes
more coherent.
Conclusions: We present a step-by-step procedure to refine an existing medical questionnaire along with its scores
illustrated and discussed by the refinement of the BCTOS.
Trial registration: Due to the character of the study (no intervention study), no registration was performed.
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Background
In clinical trials, patient reported outcomes (PRO) are
gaining more and more importance [1, 2]. PROs can
help to measure constructs (e.g., subjective well-being)
as latent variables that cannot be examined in an object-
ive way. By this, PROs are particularly appealing if the
aim is to assess subjective endpoints which often better
reflect the patient’s individual view. The assessment of
PRO is frequently performed by questionnaires, where
patients respond to various items on an ordinal Likert
scale. Thereby, the clinical researcher is often not only
interested in assessing one specific outcome, but aims to
collect several aspects related to a larger global endpoint.
For example, when assessing the global endpoint quality
of life, there are several related sub-outcomes such as
physical well-being and subjective well-being. As a con-
sequence, related questionnaires tends to be rather long
in order to assess as much information as possible (the
more aspects are measured, the longer is the question-
naire). However, the demand to answer a large amount
of questions increases the patient’s effort and can lead to
low response rates and/or bad quality of the answers.
Thus, questionnaires should be only as long as necessary
to maintain patient’s compliance. Therefore, the selec-
tion of adequate items out of a potentially large site of
candidate items (item pool) is a very important aspect of
questionnaire development.
In general, to achieve a higher reliability and content
validity in the measurement of a latent variable, multiple
items of a questionnaire are usually combined into a
single summarizing score. Especially in clinical research,
the calculation of such scores is mostly kept simple. For
example, the mean or the sum of the patient’s answers is
considered as the final score estimate, sometimes
followed by a linear transformation to an easily inter-
pretable scale (e.g. 0–100). However, from a psychomet-
ric theory view point, simple summation should be
restricted only to scores where the factor loadings result-
ing from a corresponding factorization are similar or
nearly equal, a requirement that is often not fulfilled and
hardly ever verified [3]. In the psychometric literature,
there are a number of methods that are more complex,
but also more appropriate to define such scores.
In conclusion, the selection of adequate items and an
appropriate scoring procedure are two main criteria that
guarantee a valid and reliable measurement of latent
variables which are assessed by PRO. Both aspects are
usually ignored in the clinical context, mainly because
recommendations and guidance for clinical researchers
on how to construct good questionnaires and related
scores are still missing.
This lack of guidance was one of the major challenges
for us when we were recently confronted with the task
to refine the Breast Cancer Treatment Outcome Scale
(BCTOS) [4], a PRO questionnaire to assess aesthetic
and function after breast conserving therapy in breast
cancer patients. Although this questionnaire was used in
practical application for years, it can be criticized for
being redundant in some aspects. As a consequence, the
number of items seems to be too high and the three
sub-scores of the BCTOS seem not well separated.
When facing the challenge to refine this particular ques-
tionnaire, we were confronted with very general aspects
of psychometric theory. The task thereby was to find a
good compromise between methodologic correctness
and feasibility in practical application. As this is a task
which goes far beyond the specific goal to refine the
BCTOS the aim of this article is to give an insight in our
experiences and methodological choices we made during
this refinement process. The first steps can already be
found in Hennigs et al. [5]. However, the results
presented in that paper are more focused on medical as-
pects and ended with yielding a new item factor struc-
ture. The detailed steps in refining and revising a
questionnaire with its scores goes far beyond the scope
of the former paper. For example, a number of choices
and decisions for and against the use of different meth-
odological concepts had to be made. By summarizing
our experiences, we derived a step-by-step procedure to
refine the BCTOS along with its scores that we want to
present in this article. Although the formal methods
incorporated in this step-by-step procedure are not new
from a psychometric point-of-view, we hope that applied
medical researchers and statisticians being faced with a
concrete medical questionnaire can learn and benefit
from our presented experiences and methodological
choices we made by refinement of the BCTOS. By this,
the article fills an important gap between psychometric
theory and medical application.
Methods
As an exemplary PRO questionnaire we used the Breast
Cancer Treatment Outcome Scale (BCTOS, Stanton et
al. [4]) which was designed to assess women’s subjective
evaluation of both the aesthetic and functional outcomes
after breast conservation surgery for breast cancer pa-
tients. These outcomes are directly related to patient’s
quality of life [6, 7]. This questionnaire comprises 22
items resulting in three distinct sub-scores assessing the
Aesthetic Status, the Functional Status and the Breast
Sensitivity Status [8]. Patients are instructed to rate each
item of the BCTOS on a four-point Likert scale evaluat-
ing the differences between the treated and untreated
breast (1 = no difference to 4 = large difference). There-
fore, for the resulting factor scores, which are in the ori-
ginal BCTOS version calculated by the mean of the
items corresponding to the respective sub-scores, higher
score values indicate worse outcome. Practical
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experiences during years of using the BCTOS made us
believe that the BCTOS should be revised [5]. In detail,
some of the 22 individual items of the BCTOS seem to
be redundant with respect to both wording and discrim-
inatory power, especially for items regarding functional
aspects. That might be explained by the substantial
evolution of surgical techniques to less invasive pro-
cedures in breast conserving surgery [9]. Furthermore,
the interpretation of the third subscale, i.e. the Breast
Sensitive Status, in the context of aesthetic and func-
tional outcomes is not straightforward and rises diffi-
culties. Therefore, our aim was to create a tool that
creates only two scores, one concerning the aesthetic
and one concerning for the functional outcomes after
breast conserving surgery. However, in an refined ver-
sion of the BCTOS, the information assessed by the
previous Breast Sensitive Status should not be deleted
but only be rearranged in a more intuitive way.
With respect to these points, we performed a refine-
ment of the original version of the BCTOS. The process
of refining the BCTOS was performed together with
physicians from the Department of Gynecology and
Obstetrics of the University of Heidelberg. It was based
on an a retrospectively recruited test data set (collected
between 2007 and 2012), consisting of the data of 871
patients who underwent breast conservation therapy [5].
In addition, we prospectively collected a validation data
set comprising the refined version of the BCTOS
consisting of 203 patients recruited between June 2017
and May 2018.
All analyses are performed using the statistic software
R Version 3.5 or higher [10], using the packages “psych”
[11, 12], “lavaan” [12] and “MBESS” [13].
We present a three-step procedure to refine the
BCTOS questionnaire based on the above mentioned
existing test data set and a validation data set. This
procedure was developed in context of the BCTOS,
however we hope that our experiences and methodo-
logical choices will help applied medical researchers and
statisticians by the refinement of other PRO question-
naires which are in need of improvement. In general, the
test data set used for refinement of the questionnaire
must be representative for the patient population of
interest and should be adequately large depending on
the length of the questionnaire and the number of (sub-)
scores the researcher is interested in. The validation data
set should ideally be prospectively collected. Alterna-
tively, the test data set can be split into a test and a val-
idation set. However, the observed results from the
original potentially long questionnaire may deviate from
the results of a shorter refined version and therefore we
encourage to use a prospective validation cohort. We di-
vided our refinement procedure for the BCTOS ques-
tionnaire into the following general steps:
1. Refinement of the length of the questionnaire and
the (item-factor) structure based on a test data set
2. Selection of the factor score estimation method
3. Validation of the refined questionnaire and score
with respect to validity, reliability and structure on
a validation cohort.
Results
Step 1: refinement of the length and structure
Before starting the refinement procedure, it is very im-
portant that the physician really has a deep understand-
ing of what she or he intends to measure. Then, as a
first step in our proposed refinement procedure, the
structure and the related lengths of the questionnaire
should be analyzed and then refined. The optimal length
of the questionnaire depends on among other criteria on
the choice of the factor structure. Therefore, these two
aspects should be addressed in conjunction. First, we ap-
plied a factorization algorithm based on the new selected
items to analyze the underlying structure by applying an
exploratory factor analysis. Thereby, we used the poly-
choric correlation coefficient for the correlation between
the different items, since this corresponds to the most
exact method to estimate correlations for ordinal
variables [14]. In the software R, this can be performed
by the “fa” function from the “psych” package. To do so,
the estimation method (e.g. maximum likelihood,
minimum residuals) and the rotation method (e.g. or-
thogonal, oblique) must be chosen. There exist a high
number of factor methods where each of the methods
has its advantages and disadvantages [15]. In our case,
we decided to use the minimum residual method since it
gives robust estimates even for poor, skewly distributed
items, which is a common feature of questionnaires
items [15]. Afterwards, a factor rotation method has to
be determined in order to get interpretable factor load-
ings. Since we assumed our resulting factors to be corre-
lated, because they refer to related clinical aspects, we
opted for an oblique rotation method for the BCTOS.
In the next step, we applied several methods to deter-
mine the number of underlying factors (i.e. Scree-Plot,
Kaiser-criterion, parallel-analysis [16]) and compared
them in order to guarantee a robust choice of the
number of factors. In our case, the different criteria
recommended different numbers of factors for the
BCTOS-questionnaire: The Kaiser Criterion and the
scree plot analysis suggested a two factor solution
whereas the parallel analysis suggested a four factor so-
lution. Since, from a clinical point of view, it was our
aim to get a questionnaire with only two scores (one for
aesthetic and one for function) we opted for the two fac-
tor solution. With respect to item selection, items that
do not load distinctly on one of the single factors (dis-
tinct factor loading structure per item: one factor
Feißt et al. BMC Medical Research Methodology          (2019) 19:167 Page 3 of 9
loading > 0.4 and the other factor loadings < 0.3 [8])
were first candidates that possibly can be dropped from
the pool of candidate items. In our application, the items
“breast pain”, “ability to lift objects” and “fit of shirt
sleeve” were excluded from the item pool due to not
showing distinct factor loadings.
To further reduce the subset of items, there we found
two important perspectives. First, the physician experi-
enced in the field must judge the importance and the
potential redundancy of all items from a clinical per-
spective. Second, from a statistical point of view we
identified possibly redundant items by assessing item
difficulty, item variance and item-total correlation. Item
difficulty is the mean of all patient’s answers on this spe-
cific item and item variance is the respective variance.
These two parameters are strongly related. Items with
very low or too high item difficulty have small item vari-
ance and are candidates to be dropped. The item-total
correlation measures the correlation between the item
answer of a patient and its respective sum score (without
the specific item). Items with low or negative item-total
correlation are further candidates that possibly can be
dropped. Furthermore, we investigated pair-wise poly-
choric item correlations, where we dropped one of two
highly correlated items or pooled both items into one
subsuming item. In detail, the item “fit of clothing” was
dropped due to redundancy regarding the item “fit of
bra”. Furthermore, due to high correlations, the items
“shoulder movement”, “shoulder stiffness” and “shoulder
pain” were pooled into the new item “shoulder discom-
fort”. Moreover, the items “arm movement”, “arm pain”
and “arm stiffness” were condensed into the new item
“arm discomfort”.
When choosing the most relevant subset of items, we
made sure that each (sub-)score contained a sufficient
number of items depending on the homogeneity of the
latent variable to ensure an adequate reliability [16]: for
illustration, for the homogeneous latent variable “func-
tion” of the BCTOS a small number of 4 items appears
to be sufficient, whereas for the multifaceted latent
variable “aesthetic” a larger number of items (i.e. 8) is
necessary to ensure an adequate measurement.
In conclusion, we obtained a shorter version of the
BCTOS with 12 items on two scales, referred to as the
BCTOS-12. The condensation of the former BCTOS
into the BCTOS-12 can be found in Fig. 1 and is
discussed in further detail in Hennigs et al. 2018 [5].
After these steps, we repeated the exploratory factor
analysis on 10000 bootstrapped samples from the re-
duced item set (sampling with replacement). This step
was implemented in R and can be realized via the
package “boot”. This step is required to evaluate the ro-
bustness of the new item factor. In our application, we
mimicked the answers of new combined items within
the existing test data set, by calculating the corresponding
integer-rounded mean of the original item values. As a
kind of “sensitivity” analysis we repeated this procedure
with the minimum, maximum and the median as the
Fig. 1 Condensation of old BCTOS into BCTOS-12 (BCTOS new) legend: Condensation of old BCTOS into BCTOS-12 (BCTOS new) with former and
new item assignments to the scores Aesthetic Status (AS), Functional Status (FS), Breast Symptoms (BS), New Aesthetic Status (NAS) and New
Functional Status (NFS)
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mimicked item values and found no notable differences to
the integer-rounded mean approach. Although in the
literature a relative small number of bootstrap samples
appears to be sufficient, since there is no big calculation
effort in increasing the number of samples, we decided to
generate always more than 1000 bootstrap samples [17].
We determined beforehand that if a notable (>%5, [16])
proportion of the bootstrapped samples do not confirm
the factor structure (i.e. showing the same item factor
assignment as proposed with distinct factor loadings; cri-
terion for distinct factor loadings per item: one factor
loading > 0.4 and the other factor loadings < 0.3, see
above) the current item factor combination should be
carefully reflected and the identified meaningful subset of
items should potentially be redefined again together with
the physician. Therefore, we would overthink the elimin-
ation of items and we would try to find a more robust
item factor structure, e.g. by re-introduce eliminated
items. However, concerning the BCTOS-12, 99.5% of the
bootstrap samples confirmed the distinct item factor
structure indicating a high robustness of the item factor
structure.
Step 2: selection of the factor score estimation method
In the next step, we determined a score computation
method corresponding to the identified factors. In our
application, we need to find scores for the Functional
Status and the Aesthetic Status.
Factor score computation methods can be distinguished
into two general approaches - refined and non-refined
methods.
In clinical applications, most often non-refined
methods are used, which are in the most cases simple
(unweighted) summation (or means) of the item out-
comes. Unweighted summation implies that every item
is equally influenced by the latent construct, which is
wrong when the factor loading of items differs notably.
The score computation of the original BCTOS is based
on unweighted summation, however, in the shorter ver-
sion of the BCTOS, our proposed BCTOS-12 showed
different factor loadings for the single items in the test
data set as well as for the validation data set.
As an alternative to using simple summation, weighted
sum scores are also proposed in the literature [18] and
are still considered as non-refined scoring methods. The
weights can thereby be determined, e.g. by clinical
experts or by a patient’s judgment.
In contrast to the non-refined methods, the refined
factor scores (e.g. Regression Scores, Bartlett Scores, An-
derson Rubin Scores) are based on linear combinations
of the observed variables. They are simultaneously calcu-
lated for all patients of the data set and, therefore, the
resulting patients’ score is depending on the underlying
dataset. Thereby, the aim is to “[ …] consider what is
shared between the item and the factor and what is mea-
sured” [19]. Refined factor scores can be computed in R
with the function “fa” from the “psych” package. Gener-
ally, refined methods are computationally more complex
than the non-refined methods but also more valid, i.e.
they give more accurate estimators of each patient’s
“true” level of the underlying latent variables. Based on
these considerations, a patient’s score can differ if the
item responses of the other patients are changing. This
problem is the same for the (weighted) summation ap-
proaches, with weights given as factor loadings as the
value of the respective factor loading is also depending
on the underlying dataset.
In our application, we calculated Pearson correlation
coefficients between the different factor score computa-
tion methods and the original unweighted mean factor
scores for the BCTOS-12. Despite the fact that the
factor loadings of the BCTOS-12 were considerably
different, we found extremely high correlations (> 0.95)
between all resulting factor scores estimators based on
the different approaches. From a methodologic point of
view, the refined scoring methods are superior to sum or
mean scoring methods. However, because of the de-
tected extremely high correlations we opt for the much
easier mean score as the factor score estimation method
of choice. Since the mean score is a lot of easier to
handle, we thereby hope to further encouraging the
establishment of the BCTOS in clinical research.
In summary, the advantages and challenges of using
refined or non-refined methods should be carefully
compared for the application at hand. Based on our
considerations, we saw many practical advantages by
maintaining the initial scoring method of the original
questionnaire.
Step 3: validation of the refined questionnaire and scores
After the determination of the item factor structure and
the score computation method, we tested the validity,
reliability and structure of the BCTOS-12 by a prospect-
ively collected validation cohort. Since PRO tend to
show high variability, we recruited a relatively large val-
idation cohort with a sample size > 200 [20] in order to
achieve reasonable estimators for reliability and validity.
There are different ways to examine the validity of a
questionnaire (e.g. content/divergent validity, construct
validity, criterion validity). For clinical PRO question-
naires, a widely used approach is to calculate the
construct validity by examining the convergent and
divergent validity, where the scores of the refined ques-
tionnaire are compared to a validated reference ques-
tionnaire measuring related aspects. This is done by
assessing correlations between the new factor scores and
the scores of the reference questionnaire. A question-
naire provides a high validity if its factor scores are
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reasonably correlated to the reference scores of the (vali-
dated) reference questionnaire.
To perform the validation step, we additionally col-
lected data of the EORTC QLQ C30 BR23 (European
Organization for Research and Treatment [21]), a can-
cer-specific quality of life (QoL) questionnaire, as a ref-
erence questionnaire. The EORTC QLQ C30-BR23
consists of a base module of 30 items (C30) and a breast
cancer-specific addendum of 23 items (BR23), based on
ordinal rating scales [21, 22]. The items are summarized
in several sub-scores representing different aspects of
QoL. Spearman’s rank correlation coefficients between
the new scores of the BCTOS-12 and the scores of the
QLQ C30 BR23 were calculated. The results can be seen
in Table 1. The scores showed a reasonable convergent
and divergent validity, e.g. the new aesthetic score
showed high correlations to the “Body image” and the
“Breast symptoms” score (− 0.45, 0.71), the new
functional score showed high correlations to the “Arm
symptoms” and the “Physical functioning” score (0.77, −
0.55) and, in contrary concerning the divergent validity,
both scores showed very small correlations to the “Fa-
tigue” and the “Diarrhea” score (0.05, − 0.01, 0.06, 0.03).
A fast and widely used way to get a measure for the
reliability of the new questionnaire is to assess the in-
ternal consistency. We preferred the use of McDonald’s
Omega rather than the widely used Cronbach’s alpha,
since Cronbach’s alpha is based on the assumption of
equal factor loadings and furthermore, McDonald’s
Omega can be used multidimensional, too [23]. As for
Cronbach’s alpha, McDonald’s Omega values > 0.8 can
be interpreted as a good internal reliability. For the
BCTOS-12, we obtained McDonald’s Omega of 0.888
and 0.900 indicating a good internal consistency for the
two scores of the BCTOS-12. Since we assumed corre-
lated factors, we also considered the multidimensional
McDonald’s Omega coefficient which confirmed the
good reliability of our questionnaire (Omega total =
0.908, Omega hierarchical = 0.902). Thereby, we calcu-
lated the McDonald’s Omegas based on polychoric
correlations, which again can be easily computed in R in
the “omega” function of the package “psych”.
To test the new item-factor structure, we performed a
confirmatory factor analysis [24] and analyzed its model
fit. For the estimation of the parameters of the confirma-
tory factor analysis, again an estimation method has to
be determined (e.g. robust maximum likelihood,
weighted least squares, …). Since most PRO question-
naires in clinical research have ordinal scaled item
variables, we used the weighted least squares method,
since it is distinguished as one of the most appropriate
approaches for structural equation modeling with or-
dinal observed variables, because this methods assume
that continuous latent variables were “coarsely catego-
rized by the measurement process to yield the observed
ordinal variables, and that the model proposed by the
researcher pertains to these latent variables rather than
to their ordinal manifestations” [25]. Furthermore, we
found that robust maximum likelihood and diagonally
weighted least square result in similarly appropriate
results [26].
There exists a number of different model fit measures
by which the goodness of fit can be evaluated. In gen-
eral, if we compare a new model with an existing model,
we can compare the model fits by a single fit parameter
to identify the better model. However, if there is no
comparable model, the model fit should be examined by
different descriptive measures which can be compared
to different cutoffs from the literature. In the literature it
is recommended to use several indices simultaneously to
represent different classes of goodness of fit criteria [27].
If not all of the presented fit measures meet their re-
spective cutoff, the strength of violation and the possible
impact on the model selection has to be discussed. In
order to prevent a strong violation of the cutoffs as late
Table 1 Spearman’s rank correlation coefficients
EORTC scale Aesthetic Scale Functional Scale
Physical functioning −0.48 − 0.55
Role functioning −0.54 − 0.47
Emotional functioning −0.46 − 0.33
Cognitive functioning −0.31 − 0.36
Social functioning −0.47 − 0.45
Fatigue 0.05 −0.01
Nausea and vomiting 0.2 0.2
Pain 0.53 0.55
Dyspnoea 0.19 0.31
Insomnia 0.42 0.2
Appetite loss 0.35 0.32
Constipation 0.23 0.19
Diarrhoea 0.06 0.03
Financial difficulties 0.25 0.31
Global health status −0.56 −0.48
Systematic therapy side effects 0.38 0.41
Upset by hair loss 0.1 0.11
Breast symptoms 0.71 0.48
Arm symptoms 0.41 0.77
Body Image −0.45 −0.31
Sexual functioning −0.11 − 0.15
Sexual enjoyment −0.12 − 0.22
Future perspective −0.29 − 0.27
Legend: Spearman’s rank correlation coefficients between the new scores of
the BCTOS-12 (columns) and the scores of the QLQ C30 BR23
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as in Step 3, we already calculated the fit indices in Step
1 based on the test data set and took into account the
results in the refinement procedure of the item-factor-
structure in Step 1 (see above and in Table 2). We opt
for the following fit indices because they are widely used
and recommended from the literature [16, 28–30]:
1. A root mean square error of approximation
(RMSEA) < 0.05 (acceptable fit ≤0.08) [16, 27]: The
RMSEA is an index of the difference between the
observed covariance matrix and the hypothesized
covariance matrix of model.
2. A comparative fit index (CFI) > 0.97 (≥0.95
acceptable) [16, 27]: Similar to the RMSEA the CFI
examines the discrepancy between the data and the
hypothesized model and additionally adjusts for the
sample size.
3. A Tucker-Lewis index (TLI) > 0.95 (≥0.90
acceptable) [16, 27]. The TLI analyzes the
discrepancy
between the hypothesized and null model (simplest
model) referring to the chi-squared value.
If the underlying factors of the refined questionnaire
show high correlations, higher order factor models (e.g.
bifactor, general factor models [31–33]) can improve the
model fit and strengthen the use of the questionnaire as
one single tool (instead of several different question-
naires, with separate scoring procedures).
Concerning the BCTOS-12, we used a standard con-
firmatory factor analysis as well as higher-order models
(hierarchic and bifactor model) to account for the
correlation between the factors. These were based on
the test dataset from step 1 and step 2 and based on the
validation cohort dataset, as well. The best model fit was
found for the bifactor model (see Table 2). The prefer-
ence of the bifactor model strengthens the use of the
questionnaire as a single tool and thus, indicating the
calculation of its scores to be based on all items of the
questionnaire. However, as shown above, the refined
scores in the example of the BCTOS-12 are highly cor-
related to the mean scores and in addition, the mean
scores are a lot easier to handle. Therefore, we finally
decided to maintain the initial scoring method of mean
calculation. However, these findings may provide the
basis for the development of a summary score compris-
ing all items of the questionnaire. Since the model fit
measures indicate an acceptable model fit for all of the
tested models, we considered the new two dimensional
structure of the BCTOS-12 to be verified.
Discussion
In this paper we presented a three-step procedure for
the refinement of the Breast Cancer Treatment
Outcome Scale (BCTOS [4]). The BCTOS is a PRO
questionnaire which was designed to assess women’s
subjective evaluation of both the aesthetic and functional
outcomes after breast conservation surgery for breast
cancer patients.
Our presented procedure of the original BCTOS re-
sulted in a shorter and more straightforward version, the
BCTOS-12. Based on only 12 items, the new version it
is shorter and therefore more comfortable to handle for
physicians and patients. The refined questionnaire com-
prises exactly two subscales: one subscale regarding to
the breast area concerning more aesthetic aspects and
one subscale concerning the arm and shoulder are
regarding to more functional aspects. Thus, the inter-
pretation of the subscales is more straightforward
than the interpretation of three subscales in the ori-
ginal version.
The aim of this article is to give an insight in the
methodological choices we made in order to give med-
ical researchers and statisticians being faced with the
same problem of the refinement of a PRO questionnaire
some orientation and guidance. However, the choice of
the underlying methodology should always be consid-
ered individually for the questionnaire and the medical
research field at hand. To illustrate the general points
and problems to which one is confronted during the
refinement process of a questionnaire, we tried to
formalize the methodologic steps required. However, to
give a full and complete guidance for all possible metho-
dologic aspects of a questionnaire is a very complex task
and would go beyond the scope of this article. Nonethe-
less, we did our best to provide the interested reader
with various references where a lot of further informa-
tion could be found.
Refinement of PRO questionnaires and scores is both
– a statistical and a medical task. We made the experi-
ence that the restriction to statistical aspects of the
procedure alone is not sufficient for a comprehensive re-
finement of a questionnaire. Therefore, we recommend
the cooperation between physicians and statistician, to
join their clinical and methodologic knowledge and
experience.
Table 2 Model fit measures of the confirmatory factor analysis
and its multidimensional extensions
Test data RMSEA CFI TLI Validation data RMSEA CFI TLI
Standard 0.069 0.963 0.954 Standard 0.103 0.974 0.968
Hierarchic 0.07 0.963 0.953 Hierarchic 0.105 0.974 0.967
Bifaktor 0.047 0.987 0.979 Bifaktor 0.083 0.987 0.979
Legend: Modell fit measures (RMSEA root mean square error of approximation,
CFI comparative fit index, TLI Tucker-Lewis index) of the confirmatory factor
analysis (Standard) and its multidimensional extension (Hierarchic, Bifaktor) of
the test data (existing) and the validation data (prospective collected)
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However, the statistical has a strong impact. We tried
to give an insight in the existing methods and recom-
mendations for the choice and determination of the
required statistical key methods and parameters. We
thereby took into account the actual state of the art in
the field of psychometrics. For example, we used McDo-
nald’s Omega instead of Cronbach’s alpha as a measure
of the internal consistency. Similarly, we found poly-
choric correlations to be a more complex but better
approach for the calculation of correlations between
ordinal variables than Spearman’s rank correlation
coefficient [34].
Furthermore, we analyzed various factor score estima-
tion methods. From a statistical point of view, the
refined methods are superior to non-refined methods,
e.g. refined methods give more accurate estimators for
the factor scores with less bias than scores based on
(weighted) sum scores. However, they are not easy to
compute, compared to a simple summation algorithm,
and they have to be based on a notably large data set to
guarantee reliable estimators. Therefore, these methods
are currently only rarely applied in a clinical research.
However, in our application, we found extremely high
correlations between the refined factor score estimators
and the mean factor score estimators, indicating the
additional benefit for using these complex methods can
be moderate in specific applications. Therefore, to en-
courage the use of the BCTOS-12 in clinical practice,
we prefer to rely on the mean factor scores estimators
for the BCTOS-12 subscales.
In general, one should bear in mind that the procedure
of refining a questionnaire is a task that is financially
expensive and time consuming. Especially the necessary
recruitment of a validation cohort, resulted in a great fi-
nancial effort and a high time requirement. Nonetheless,
this effort is necessary, since there is an increasing use
of PROs in medical research and it gets more and more
important to have reliable questionnaires with appropri-
ate scores for measuring subjective latent factors.
Conclusion
In this work, we illustrated a possible step-by-step
procedure to refine an existing questionnaire with its
scores by a clinical PRO example. Psychometrics offers a
huge amount of tools for the adequate refinement of
questionnaires that are waiting to be used in the field of
medical research.
We hope this paper can contribute to bring the method-
ology of clinical research with PRO on the “next level”.
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